Clovis Oncology success in European Opposition Proceedings related to Rubraca®
10 Dec 2018
Clovis Oncology has announced that the European Patent Office (EPO) last week upheld claims of European Patent 2534153 in amended form covering certain.
Morphosis: creating and nurturing biotech start-ups in Singapore
31 Oct 2018
We understand that early-stage biotech companies do not have it easy. It is a long road from pre-clinical research to bringing a product or treatment.